Cannabinoids Inhibit T-cells via Cannabinoid Receptor 2 in an In Vitro Assay for Graft Rejection, the Mixed Lymphocyte Reaction
- 4 July 2013
- journal article
- research article
- Published by Springer Nature in Journal of Neuroimmune Pharmacology
- Vol. 8 (5) , 1239-1250
Abstract
Cannabinoids are known to have anti-inflammatory and immunomodulatory properties. Cannabinoid receptor 2 (CB2) is expressed mainly on leukocytes and is the receptor implicated in mediating many of the effects of cannabinoids on immune processes. This study tested the capacity of Δ9-tetrahydrocannabinol (Δ9-THC) and of two CB2-selective agonists to inhibit the murine Mixed Lymphocyte Reaction (MLR), an in vitro correlate of graft rejection following skin and organ transplantation. Both CB2-selective agonists and Δ9-THC significantly suppressed the MLR in a dose dependent fashion. The inhibition was via CB2, as suppression could be blocked by pretreatment with a CB2-selective antagonist, but not by a CB1 antagonist, and none of the compounds suppressed the MLR when splenocytes from CB2 deficient mice were used. The CB2 agonists were shown to act directly on T-cells, as exposure of CD3+ cells to these compounds completely inhibited their action in a reconstituted MLR. Further, the CB2-selective agonists completely inhibited proliferation of purified T-cells activated by anti-CD3 and anti-CD28 antibodies. T-cell function was decreased by the CB2 agonists, as an ELISA of MLR culture supernatants revealed IL-2 release was significantly decreased in the cannabinoid treated cells. Together, these data support the potential of this class of compounds as useful therapies to prolong graft survival in transplant patients.Keywords
This publication has 72 references indexed in Scilit:
- Modulation of Inflammatory Responses by a Cannabinoid-2–Selective Agonist after Spinal Cord InjuryJournal of Neurotrauma, 2011
- Brain cannabinoid CB2 receptors modulate cocaine's actions in miceNature Neuroscience, 2011
- A Longitudinal Proton Magnetic Resonance Spectroscopy Study of Mild Traumatic Brain InjuryJournal of Neurotrauma, 2011
- Do cannabinoids have a therapeutic role in transplantation?Trends in Pharmacological Sciences, 2010
- Cannabinoid Receptor Type 1- and 2-mediated Increase in Cyclic AMP Inhibits T Cell Receptor-triggered SignalingJournal of Biological Chemistry, 2009
- CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injuryMicrovascular Research, 2009
- Modulation of Cannabinoid Receptor Activation as a Neuroprotective Strategy for EAE and StrokeJournal of Neuroimmune Pharmacology, 2009
- Anandamide and Δ9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptorsJournal of Neuroimmunology, 2007
- Cannabinoid CB2 Receptor Activation Decreases Cerebral Infarction in a Mouse Focal Ischemia/Reperfusion ModelJournal of Cerebral Blood Flow & Metabolism, 2007
- CB2 cannabinoid receptor agonist, JWH-015, triggers apoptosis in immune cells: Potential role for CB2-selective ligands as immunosuppressive agentsClinical Immunology, 2007